Niloofar Rahmani

Array ( [id] => 10451886 [patent_doc_number] => 20150336899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'MORPHINAN COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/726758 [patent_app_country] => US [patent_app_date] => 2015-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16459 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14726758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11793144 [patent_doc_number] => 09402833 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors' [patent_app_type] => utility [patent_app_number] => 14/725683 [patent_app_country] => US [patent_app_date] => 2015-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34867 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14725683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10374335 [patent_doc_number] => 20150259341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'IMIDAZOPYRIDINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 14/723061 [patent_app_country] => US [patent_app_date] => 2015-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7525 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14723061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13013827 [patent_doc_number] => 10030021 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-24 [patent_title] => Spirocyclic morphinans and use thereof [patent_app_type] => utility [patent_app_number] => 15/313323 [patent_app_country] => US [patent_app_date] => 2015-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23551 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10468545 [patent_doc_number] => 20150353559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'NEW BICYCLIC DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 14/719063 [patent_app_country] => US [patent_app_date] => 2015-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64767 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14719063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10754941 [patent_doc_number] => 20160101092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-14 [patent_title] => '1H-PYRAZOLO[3,4-B]PYRIDINES AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/718354 [patent_app_country] => US [patent_app_date] => 2015-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24881 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14718354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10627571 [patent_doc_number] => 09345709 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => '1,5-naphthyridine derivatives and MELK inhibitors containing the same' [patent_app_type] => utility [patent_app_number] => 14/719075 [patent_app_country] => US [patent_app_date] => 2015-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 67466 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14719075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12086791 [patent_doc_number] => 09840511 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-12 [patent_title] => '2-(aryl or heteroaryl-)phenyl (AZA)benzofuran compounds for the treatment of hepatitis C' [patent_app_type] => utility [patent_app_number] => 15/312022 [patent_app_country] => US [patent_app_date] => 2015-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7764 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12526731 [patent_doc_number] => 10005753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-26 [patent_title] => Methods for producing beraprost and its derivatives [patent_app_type] => utility [patent_app_number] => 15/312295 [patent_app_country] => US [patent_app_date] => 2015-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21448 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10361912 [patent_doc_number] => 20150246918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'IMIDAZOPYRIDINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 14/712495 [patent_app_country] => US [patent_app_date] => 2015-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8059 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14712495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10361916 [patent_doc_number] => 20150246920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'NOVEL CRYSTALLINE FORMS OF TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE SODIUM SALT' [patent_app_type] => utility [patent_app_number] => 14/711162 [patent_app_country] => US [patent_app_date] => 2015-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29850 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14711162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12448191 [patent_doc_number] => 09981915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-29 [patent_title] => Compounds for treatment of cancer [patent_app_type] => utility [patent_app_number] => 15/309357 [patent_app_country] => US [patent_app_date] => 2015-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 22940 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15309357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10347460 [patent_doc_number] => 20150232466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'NOVEL HETEROCYCLIC ACRYLAMIDES AND THEIR USE AS PHARMACEUTICALS' [patent_app_type] => utility [patent_app_number] => 14/703004 [patent_app_country] => US [patent_app_date] => 2015-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 63994 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14703004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11205110 [patent_doc_number] => 09434727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-06 [patent_title] => 'Substituted 4-phenylpiperidines, their preparation and use' [patent_app_type] => utility [patent_app_number] => 14/699672 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 55488 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11471175 [patent_doc_number] => 20170057958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'ENANTIOMERS OF THE N-(2-AMINO-5-FLUORO-2-METHYLPENTYL)-8-[(2,6-DIFLUOROBENZYL)OXY]-2-METHYLIMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE, AS WELL AS OF THE DI- AND TRIFLUORO DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 15/308279 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22348 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11555161 [patent_doc_number] => 20170101407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-13 [patent_title] => '6-CHLORINE-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE CARBOXAMIDES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE STIMULATORS' [patent_app_type] => utility [patent_app_number] => 15/308200 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22971 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10361910 [patent_doc_number] => 20150246916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'Substituted 6, 5-Fused Bicyclic Heteroaryl Compounds' [patent_app_type] => utility [patent_app_number] => 14/699100 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60390 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11799580 [patent_doc_number] => 09540369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-10 [patent_title] => 'Use of kinase inhibitors to increase the susceptibility of gram positive bacteria to beta lactam antibiotics' [patent_app_type] => utility [patent_app_number] => 14/695813 [patent_app_country] => US [patent_app_date] => 2015-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 60 [patent_no_of_words] => 13007 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14695813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11443157 [patent_doc_number] => 20170044179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/305476 [patent_app_country] => US [patent_app_date] => 2015-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6631 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10712595 [patent_doc_number] => 20160058742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-03 [patent_title] => 'FUSED AMINO PYRIDINE AS HSP90 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/681310 [patent_app_country] => US [patent_app_date] => 2015-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45583 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14681310 [rel_patent_id] =>[rel_patent_doc_number] =>)